{
    "clinical_study": {
        "@rank": "46888", 
        "arm_group": [
            {
                "arm_group_label": "Saline+glucose nasal spray", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Nasal spray with saline+glucose twice daily for 3 months"
            }, 
            {
                "arm_group_label": "Nasal spray with glucose oxidase+glucose", 
                "arm_group_type": "Active Comparator", 
                "description": "Nasal spray in a bag-on-valve device with 50U/ml glucose oxidase + 5% glucose in isotone saline. Dosage: One puff in each nostril twice daily for 3 months."
            }
        ], 
        "brief_summary": {
            "textblock": "To investigate if use of glucosoxidas nasal spray can reduce the number of days with\n      rhinitis and/or otitis in children beyond 4 years."
        }, 
        "brief_title": "Nasal Spray With Glucose Oxidase Preventing Common Cold in Pre-school Children", 
        "completion_date": {
            "#text": "June 2013", 
            "@type": "Actual"
        }, 
        "condition": [
            "Upper Respiratory Tract Infections", 
            "Acute Otitis Media"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Otitis", 
                "Otitis Media", 
                "Respiratory Tract Infections"
            ]
        }, 
        "detailed_description": {
            "textblock": "Children below 4 years of age and in public day care were invited to participate in this\n      prospective study. The children started with a visit to an ENT doctor and after inclusion\n      the children started to spray twice daily with glucose oxidase+glucose or only\n      saline+glucose for 3 months. During this period the parents were asked to fill in a home\n      protocol recording upper respiratory tract symptoms as: rhinitis, cough, fever, ear ache.\n      The parent were told to go to the ENT department if they suspected an episode of acute\n      otitis media. After 6 weeks and 12 weeks the children had scheduled visits to the ENT\n      department. After 12 weeks of treatment a nasopharyngeal swab was taken for bacterial\n      culture."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Children below 4 years of age\n\n        Exclusion Criteria:\n\n          -  None"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "3 Years", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "April 23, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01883427", 
            "org_study_id": "GObarn2013"
        }, 
        "intervention": [
            {
                "arm_group_label": "Nasal spray with glucose oxidase+glucose", 
                "description": "Glucose oxidase is a hydrogen peroxide producing enzyme, imitating the inhibitory effects of the normal bacterial flora of the nasopharynx", 
                "intervention_name": "Glucose oxidase", 
                "intervention_type": "Other", 
                "other_name": "Nasal spray containing isotonic saline+glucose oxidase+5% glucose"
            }, 
            {
                "arm_group_label": "Saline+glucose nasal spray", 
                "description": "A bag on valve nasal spray device containing isotone saline and 5% glucose", 
                "intervention_name": "Saline + glucose", 
                "intervention_type": "Other", 
                "other_name": "Nasal spray containing isotonic saline+5% glucose"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Days with URTI symptoms", 
            "episodes of AOM"
        ], 
        "lastchanged_date": "June 24, 2013", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Pite\u00e5", 
                        "country": "Sweden"
                    }, 
                    "name": "\u00d6ronmottagningen"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sunderbyn", 
                        "country": "Sweden"
                    }, 
                    "name": "\u00d6ronmottagningen"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sundsvall", 
                        "country": "Sweden"
                    }, 
                    "name": "\u00d6ronmottagningen"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "\u00d6stersund", 
                        "country": "Sweden"
                    }, 
                    "name": "\u00d6ronmottagningen"
                }
            }
        ], 
        "location_countries": {
            "country": "Sweden"
        }, 
        "number_of_arms": "2", 
        "official_title": "Placebo Controlled Study Among Children Below Four Years of Age, Investigating Whether a Glucose Oxidase Nasal Spray Can Reduce Days With Upper Respiratory Tract Infection Symptoms and Episodes of Otitis Media", 
        "overall_official": [
            {
                "affiliation": "V\u00e4sternorrlands Landsting", 
                "last_name": "Eva Westman, MD, PhD", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "J\u00e4mtlands Landsting", 
                "last_name": "Marie Ryding, MD, PhD", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "Norrbottens Landsting", 
                "last_name": "Anders Niklasson, MD", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "Norrbottens Landsting", 
                "last_name": "Helena Toolanen, MD", 
                "role": "Study Chair"
            }
        ], 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Sweden: Regional Ethical Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "May 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Upper respiratory tract infection symptoms during a 3 months period are recorded in a home protocol by the parents of the children.", 
            "measure": "Does a nasal spray with glucose oxidase reduce number of days with upper respiratory infectious symptoms and/or episodes of acute otitis media?", 
            "safety_issue": "Yes", 
            "time_frame": "3 months of recording"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01883427"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Ume\u00e5 University", 
            "investigator_full_name": "Krister Tano", 
            "investigator_title": "MD, PhD", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "source": "Ume\u00e5 University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Krister Tano", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "June 2013"
    }
}